As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is ...

Amanda Smith is a freelance journalist and writer. She reports on culture, society, human interest and technology. Her stories hold a mirror to society, reflecting both its malaise and its beauty.

The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...

Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.

A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...